ShareValue scores for 300238.SHE: Valuation 28, Quality 52, Growth 44, Health 39.

300238.SHE
SZSE

Guanhao Biotech Co Ltd

CN¥11.67(+2.55%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-9% to 9%
Valuation
28
Overvalued
Price vs Value
Quality
52
Moderate
Business Strength
Growth
44
Moderate
Revenue & Earnings
Health
39
Stressed
Financial Stability
Momentum
26
Bearish
Price Trend

Company Details

About

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream for psoriasis. In addition, it offers artificial lens and medical instruments; and cell technology services. Its products can be used in neurosurgery, thoracic general surgery, ophthalmology, dermatology, orthopedics, cosmetology, plastic surgery, and other areas. Guanhao Biotech Co.,Ltd. was founded in 1999 and is headquartered in Guangzhou, China. Address: No. 12 Yuyan Road, Guangzhou, China, 510530

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026